Upgrade to SI Premium - Free Trial

Form EFFECT Lyell Immunopharma, Inc.

April 15, 2026 6:23 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 14, 2026 4:00 P.M.
Form: S-3
CIK: 0001806952
Company Name: Lyell Immunopharma, Inc.
File Number: 333-294884

Categories

SEC Filings